Kite Pharma ^Investors

Kite Pharma is a development-stage biotechnology company that is dedicated to curing cancer. They design and develop immune-based therapies to treat various cancer indications. Their portfolio includes proprietary product candidates that stimulate the patient's own immune system to fight tumor cells, offering novel strategies for the treatment and management of different tumor types. Kite Pharma's focus is on cell therapy, specifically CAR T-cell therapy, which is a custom-made, one-time cancer treatment that harnesses the power of the immune system to target and attack cancer cells. They are constantly working to improve patients' responses to cell therapy and explore new ways to treat and cure cancer.